N-Asn
Modify Date: 2024-01-21 10:59:00
N-Asn structure
|
Common Name | N-Asn | ||
|---|---|---|---|---|
| CAS Number | 2776-93-4 | Molecular Weight | 335.31000 | |
| Density | 1.53g/cm3 | Boiling Point | 818.5ºC at 760mmHg | |
| Molecular Formula | C12H21N3O8 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | 448.8ºC | |
Use of N-AsnH-Asn(glcnac-beta-D)-OH is an endogenous metabolite present in Urine that can be used for the research of NGLY1-CDDG[1][2]. |
| Name | N4-(β-N-acetyl-D-glucosaminyl)-L-asparagine |
|---|---|
| Synonym | More Synonyms |
| Description | H-Asn(glcnac-beta-D)-OH is an endogenous metabolite present in Urine that can be used for the research of NGLY1-CDDG[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | Endogenous metabolites is defined as those that are annotated by Kyoto Encyclopedia of Genes and Genomes as substrates or products of the ~1900 metabolic enzymes encoded in our genome. It is clear in the body of literature that there are documented toxic properties for many of these metabolites[1]. |
| References |
| Density | 1.53g/cm3 |
|---|---|
| Boiling Point | 818.5ºC at 760mmHg |
| Molecular Formula | C12H21N3O8 |
| Molecular Weight | 335.31000 |
| Flash Point | 448.8ºC |
| Exact Mass | 335.13300 |
| PSA | 191.44000 |
| Vapour Pressure | 4.86E-31mmHg at 25°C |
| Index of Refraction | 1.6 |
| Storage condition | 2-8°C |
| RIDADR | NONH for all modes of transport |
|---|---|
| WGK Germany | 3 |
CAS#:90-76-6
CAS#:56-84-8
CAS#:7512-17-6
CAS#:13010-39-4|
Synthesis of N4-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-L-asparagine analogues. n-Butyramide, 3-chloropropionamide, 3-aminopropionamide, and isovaleramide analogues.
Carbohydr. Res. 331(4) , 439-44, (2001) The syntheses of four analogues of N4-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-L-asparagine are described. Activated carboxylic acids were reacted with 2-acetamido-2-deoxy-beta-D-glucopyranosylamin... |
|
|
Aspartylglycosaminuria: biochemistry and molecular biology.
Biochim. Biophys. Acta 1455(2-3) , 139-54, (1999) Aspartylglucosaminuria (AGU, McKusick 208400) is an autosomal recessive lysosomal storage disease caused by defective degradation of Asn-linked glycoproteins. AGU mutations occur in the gene (AGA) for... |
|
|
Angiokeratoma corporis diffusum in a Spanish patient with aspartylglucosaminuria.
Br. J. Dermatol. 147(4) , 760-4, (2002) Angiokeratoma corporis diffusum (ACD), initially considered to be synonymous with Fabry's disease, represents a well-known cutaneous marker of some other lysosomal enzyme disorders. Aspartylglucosamin... |
| 2-Acetamido-1-N-(β-L-aspartyl)-2-deoxy-β-D-glucopyranosylamine |
| N(4)-(beta-N-acetyl-D-glucosaminyl)-L-asparagine |
| 2-Acetamido-2-deoxy-b-D-glucopyranosyl L-asparagine |